Study finds gene therapy treatment for leukemia still effective 10 years later
Doctors at the University of Pennsylvania say that 10 years after treating two leukemia patients with an experimental gene therapy, both men were still in remission.
The doctors wrote about the cases in a study published Wednesday in the journal Nature. The treatment is called CAR-T cell therapy, and involves genetically changing T cells so they immediately attack cancer, The Associated Press reports. The cells remain in the body for years, and as they evolve, they keep the cancer at bay.
This was the first time the therapy has been studied for 10 years, the doctors said, and based on the results, "we can now conclude that CAR-T cells can actually cure patients of leukemia," said Dr. Carl June, an author of the study.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The treatment only has to be done one time, with the patient's T cells collected, modified, and then returned through an IV. Doug Olson, one of the men who received the gene therapy, was first diagnosed with chronic lymphocytic leukemia in 1996. He said that several weeks after going through the treatment in 2010, his doctor told him, "We cannot find a single cancer cell in your body."
Olson, 75, told AP he is still doing "great," and remains "very active. I was running half marathons until 2018. This is a cure. And they don't use the word lightly." The other patient doctors tracked also did well after the treatment, and died of COVID-19 complications last year.
In the U.S. and several other countries, CAR-T cell therapies are now approved for some blood cancers, and scientists are hopeful that there will soon be similar treatments for other types of cancers.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
You Are Here: the new David Nicholls 'past-their-prime' romance
The Week Recommends 'Midlife disenchantment' gives way to romance for two walkers on a cross-country hike
By Adrienne Wyper, The Week UK Published
-
The new powers to stop stalking in the UK
The Explainer Updated guidance could help protect more victims, but public is losing trust in police and battered criminal justice system
By Harriet Marsden, The Week UK Published
-
'Criminal trail?'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published